XML 23 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Schedule of Segment Perfomance Measures by Segment) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Segment Reporting Information [Line Items]    
Net sales $ 129,261 $ 111,748
Gross profit 33,734 21,505
Income before income taxes 17,574 7,622
Operating Segments [Member] | Human Health [Member]
   
Segment Reporting Information [Line Items]    
Net sales 38,694 26,409
Gross profit 11,141 8,103
Income before income taxes 5,535 3,119
Operating Segments [Member] | Pharmaceutical Ingredients [Member]
   
Segment Reporting Information [Line Items]    
Net sales 48,424 40,608
Gross profit 15,262 6,576
Income before income taxes 11,004 2,553
Operating Segments [Member] | Performance Chemicals [Member]
   
Segment Reporting Information [Line Items]    
Net sales 42,143 44,731
Gross profit 7,331 6,826
Income before income taxes 3,302 3,085
Unallocated Corporate [Member]
   
Segment Reporting Information [Line Items]    
Income before income taxes $ (2,267) $ (1,135)